Total Assets - Skye Bioscience Inc (NASDAQ:SKYE) - Alpha Spread

Skye Bioscience Inc
NASDAQ:SKYE

Watchlist Manager
Skye Bioscience Inc Logo
Skye Bioscience Inc
NASDAQ:SKYE
Watchlist
Price: 5.49 USD 4.77% Market Closed
Market Cap: 154.1m USD
Have any thoughts about
Skye Bioscience Inc?
Write Note

Skye Bioscience Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Skye Bioscience Inc
Total Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Skye Bioscience Inc
NASDAQ:SKYE
Total Assets
$87.3m
CAGR 3-Years
151%
CAGR 5-Years
95%
CAGR 10-Years
87%
Abbvie Inc
NYSE:ABBV
Total Assets
$141.9B
CAGR 3-Years
-1%
CAGR 5-Years
20%
CAGR 10-Years
17%
Gilead Sciences Inc
NASDAQ:GILD
Total Assets
$53.6B
CAGR 3-Years
-8%
CAGR 5-Years
-3%
CAGR 10-Years
6%
Amgen Inc
NASDAQ:AMGN
Total Assets
$90.9B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Assets
$20.1B
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Assets
$36.1B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Skye Bioscience Inc's Total Assets?
Total Assets
87.3m USD

Based on the financial report for Jun 30, 2024, Skye Bioscience Inc's Total Assets amounts to 87.3m USD.

What is Skye Bioscience Inc's Total Assets growth rate?
Total Assets CAGR 10Y
87%

Over the last year, the Total Assets growth was 3 796%. The average annual Total Assets growth rates for Skye Bioscience Inc have been 151% over the past three years , 95% over the past five years , and 87% over the past ten years .

Back to Top